Skip to main content
. Author manuscript; available in PMC: 2019 Apr 17.
Published in final edited form as: Immunity. 2018 Apr 17;48(4):799–811.e9. doi: 10.1016/j.immuni.2018.03.026

Figure 2. Isolated MAb neutralizes EBV infection in epithelial cells and B cells.

Figure 2

Serial dilutions of the indicated antibodies were evaluated for their ability to neutralize (A) AKTA-GFP EBV infection of epithelial (SVKCR2) cells or (B) B95.8/F EBV infection of B (Raji) cells. Anti-gH/gL antibodies are shown in shades of blue, anti-gB antibodies are shown in shades of red, and the anti-gp350 antibody (72A1) is shown in gray in B. The human or murine origins of the antibodies are indicated in the legend. Data points are mean ± SD of duplicate wells. Representative curves from 2 to 6 replicates are shown.